Doctor profile · Federal record

Dr. Amreen Sitabkhan

Dermatology Physician (CMS: Dermatology) · Dallas, TX

  • NPI 1467988642
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 9 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
12740 Hillcrest RD Ste 200
Dallas, TX 752302012
(972) 386-9600
Mailing address
5310 Harvest Hill RD, Ste 290
Dallas, TX 752305826

Credentials & registration

NPPES · NUCC
NPI registered
May 2017 — 9 yrs on file
Profile last updated
August 23, 2022
Year of graduation
2017 — 9 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Texas #T0940

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1467988642. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,496
Distinct HCPCS
10
Medicare allowed
$153,195
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 797 147 $7
99213 Established patient office or other outpatient visit, 20-29 minutes 515 371 $88
17000 Destruction of precancer skin growth, 1 growth 313 224 $49
17110 Destruction of skin growth, 1-14 growths 266 214 $110
11102 Biopsy of related skin growth, first growth 159 139 $86
99214 Established patient office or other outpatient visit, 30-39 minutes 147 91 $125
99203 New patient office or other outpatient visit, 30-44 minutes 77 77 $109
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 49 19 $1
99212 Established patient office or other outpatient visit, 10-19 minutes 39 37 $56
11103 Biopsy of related skin growth, each additional growth 35 25 $50

In context: peer comparison

Among 51 peers in Dallas Dermatology Physician, average services per provider: 218. This provider delivers 11× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,258
Transactions
133
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Regeneron Healthcare Solutions, INC. 19 $334.89
Lilly USA, LLC 17 $257.86
Janssen Biotech, INC. 13 $235.94
Abbvie INC. 17 $224.98
Sun Pharmaceutical Industries INC. 11 $201.33
E.R. Squibb & Sons, L.L.C. 15 $187.33
Ucb, INC. 9 $163.53
Amgen INC. 11 $140.53
Genzyme Corporation 5 $134.10
Novartis Pharmaceuticals Corporation 2 $62.54
Incyte Corporation 3 $56.56
Dermavant Sciences, INC. 3 $53.69
Ortho Dermatologics, A Division of Bausch Health US, LLC 3 $53.46
Arcutis Biotherapeutics, INC. 3 $52.12
Fidia Pharma USA INC. 2 $38.66

By nature of payment

Food and Beverage
$2,258

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
688
Patients
370
Total drug cost
$164,228
Drug Type Claims Patients Total cost
Ketoconazole Generic 162 81 $4,346
Triamcinolone Acetonide Generic 123 82 $1,461
Clobetasol Propionate Generic 97 60 $7,104
Mupirocin Generic 69 39 $566
Hydrocortisone Generic 51 40 $379
Clindamycin Phosphate Generic 49 29 $2,039
Fluocinonide Generic 22 13 $1,469
Doxycycline Hyclate Generic 21 15 $452
Metronidazole Generic 18 0 $1,831
Humira(Cf) Pen (Adalimumab) Brand 14 0 $143,049

Frequently asked questions

Auto-generated from federal data
What is Dr. Amreen Sitabkhan's medical specialty?
Dr. Amreen Sitabkhan practices Dermatology Physician in Dallas, TX.
Where does Dr. Amreen Sitabkhan practice?
Dr. Amreen Sitabkhan practices at 12740 Hillcrest RD Ste 200, Dallas, TX 752302012. Office phone: 9723869600.
What is Dr. Amreen Sitabkhan's NPI?
Dr. Amreen Sitabkhan's National Provider Identifier (NPI) is 1467988642, issued by NPPES.
Does Dr. Amreen Sitabkhan accept Medicare assignment?
Yes. Dr. Amreen Sitabkhan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Amreen Sitabkhan commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.